Functional Food Ingredients Market (By Type: Probiotics, Proteins & amino acids, Phytochemicals & plant extracts, Prebiotics, Others; By Source: Natural, Animal, Microbial, Plant, Synthetic; By Application: Food & Bevarages, Personal Care, Pharmaceuticals, Animal Feed, Others; By Health Benefits; By Product) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Functional Food Ingredients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Functional Food Ingredients Market, by Type, 2022-2030
8.1.1. Probiotics
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Proteins & amino acids
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Phytochemicals & plant extracts
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Prebiotics
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
9.1. Functional Food Ingredients Market, by Source, 2022-2030
9.1.1. Natural
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Animal
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Microbial
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Plant
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Synthetic
9.1.5.1. Market Revenue and Forecast (2017-2030)
10.1. Functional Food Ingredients Market, by Product, 2022-2030
10.1.1. Maltodextrin
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Probiotics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Polydextrose
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Modified Starch
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
11.1. Functional Food Ingredients Market, by Health Benefits, 2022-2030
11.1.1. Gut health
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Cardiovascular health
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Bone health
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Immunity
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Nutritive health
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Weight management
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Others
11.1.7.1. Market Revenue and Forecast (2017-2030)
12.1. Functional Food Ingredients Market, by Application, 2022-2030
12.1.1. Food
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Beverages
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Personal Care
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Pharmaceuticals
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Animal Feed
12.1.5.1. Market Revenue and Forecast (2017-2030)
12.1.6. Others
12.1.6.1. Market Revenue and Forecast (2017-2030)
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Source (2017-2030)
13.1.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.1.5. Market Revenue and Forecast, by Application (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.1.7. Market Revenue and Forecast, by Application (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Application (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.2.5. Market Revenue and Forecast, by Application (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.7. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.2.8. Market Revenue and Forecast, by Application (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.10. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.2.11. Market Revenue and Forecast, by Application (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.2.13. Market Revenue and Forecast, by Application (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.2.15. Market Revenue and Forecast, by Application (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.3.5. Market Revenue and Forecast, by Application (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.3.7. Market Revenue and Forecast, by Application (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.3.9. Market Revenue and Forecast, by Application (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Application (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Application (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.4.5. Market Revenue and Forecast, by Application (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.4.7. Market Revenue and Forecast, by Application (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.4.9. Market Revenue and Forecast, by Application (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Application (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Application (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Source (2017-2030)
13.5.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.5.5. Market Revenue and Forecast, by Application (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.5.7. Market Revenue and Forecast, by Application (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.1. Archer Daniels Midland Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Ingredion Incorporated
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Golden Grain Group Limited
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. FMC Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Omega Protein Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. NutriBiotic
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Cargill Incorporated
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Tate & Lyle plc
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Roquette Frères
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample